Table of Contents - Vertu Medical...
Transcript of Table of Contents - Vertu Medical...
Pag
e1
Pag
e2
Table of Contents
1. SURGICAL INSTRUMENT TECHNOLOGIES…………………..... 3
2. CRITICAL CARE OXYGEN SATURATION DETECTION
DEVICES………………………………………………………………….. 6
3. AIRWAY MANAGEMENT TECHNOLOGIES…………………….. 9
4. PREVENTION OF SUDDEN CARDIAC DEATH IN
ATHLETES………………………………………………………………. 11
5. REVOLUTIONARY SUMMATION EKG TECHNOLOGIES….... 13
6. VARIABLE FREQUENCY UV LIGHT STERILIZATION………. 15
7. SUMMATION TECHNOLOGIES APPLIED TO PHYSIOLOGIC
DATA DETECTION…………………………………………………….. 17
8. FEMININE HYGIENE TECHNOLOGIES………………………..... 18
9. BIOPHASIC SENSORY STIMULATION TECHNOLOGIES……. 20
10. INFANT ENVIRONMENT TECHNOLOGIES……………………21
Pag
e3
1. SURGICAL INSTRUMENT TECHNOLOGIES
BRIEF ABSTRACT:
Benefits: Allows ambidextrous surgical instrument use, introduces
ambidextrous surgical technique training, and reduces surgical errors.
Both right and left-handed surgeons can operate more efficiently.
Reduces cost of purchasing multiple sets of surgical instruments.
Technology: Proprietary, patent pending locking mechanism and
design.
Market Impact: Estimate $250 million per year
Industry Insights:
CLICK HERE TO VIEW VMT SURGICAL INSTRUMENT VIDEO
Pag
e4
Proof of market size: Global Surgical Equipment Market was valued
at $9,783.8 million in 2016 and is expected to reach $15,737.1 million
by 2023 supported by a CAGR of 7.0% during the forecast period
2017 to 2023. Surgical equipment are the medical devices used to cut,
coagulate, desiccate, and fulgurate the body tissues during the surgical
procedures.
(Source: https://www.alliedmarketresearch.com/surgical-equipment-market)
Development Stage: Engineered, tested, ready for market
Time to Market: 12 - 18 months
EXPANDED ABSTRACT:
Vertu Medical will soon be a disruptor in the surgical instrument arena with the
introduction of our revolutionary new surgical instruments design and
technologies. Vertu Medical has solved the Gordian Knot impasse of centuries old
surgical instrument designs; laden with inherent design flaws, that have proven to
have unintentional negative consequences to patients. A primary example of
conventional surgical instrument design flaws is that of the locking mechanism.
Those instruments that require locking mechanisms are right hand biased to the
degree that left-handed medical students are often dissuaded from applying for
surgical residency positions. Additionally, even right-hand dominant surgeons are
often forced to disengage locked surgical instruments with the left hand when they
are performing emergency interventions or being positioned across the surgical
table, even in a controlled setting, assuming the role of assistant surgeon. This
unorthodox disengagement of the conventional locking mechanisms has proven too
often to damage delicate tissues or structures of the patient or animal undergoing a
surgical procedure.
Over the past fifty years or so, as technology advanced, many attempts have been
made to provide viable solutions to the right-hand biased locking mechanisms
which have resulted in alternative configurations that simply have not nor will not
ever be adopted in the surgical instrument arena. Often these attempts have
mandated additional attachments to the instrument, additional maneuvers required
to reverse the locking mechanism components or designs so cumbersome that the
instrument itself would probably pose a danger to delicate structures. Simply put, a
surgeon is not going to use any new instrument design that significantly looks
different from what he or she has been trained with or requires additional
maneuvers to achieve the same function. Also, with healthcare cost constraints
being as they are, surgical companies would not be able to compete by
manufacturing surgical instruments with additional components that would require
Pag
e5
additional manufacturing equipment and assembly labor. More so, even a single
case of a lost component, from those attempted designs requiring them, left inside
a patient would legally devastate the company that produced it. Also, the FDA in
the United States has yet to approve any of these alternative versions.
Vertu Medical Technologies took on this century old surgical instrument locking
mechanism problem and did what has been said to be impossible. Vertu’s novel medical
instrument designs coupled with the means and methods provided offer several distinct
advantages over current and prior art. One improvement, utilizing the provided design of
inventor’s surgical and medical instrument releasable locking device, for those
instruments requiring such components, provides a permanently attached, rigid, durable
locking device that is vertically oriented thereby permitting an identical left and right
handed surgical technique to engage or disengage the locking mechanism of the device.
Our petitioned solution provides an improved ergonomic design and locking section
serving to replace the existing instrument handle section and locking sections of those
surgical and medical instruments that function with pivotally connected angular lever
arms that scissors to open and close a gripping section. The improved horizontally
oriented releasable locking device section provided allows an ambidextrous user means
for engaging and disengaging the locking devices with identical surgically trained
technique whether user’s left or right hand is being utilized. The invention’s novel design
grants the surgical and medical instrument industry a universally designed instrument and
locking device applicable to any and all medical and surgical instruments requiring such
a locking component for applicable function, capable of performing traditional and
ambidextrous utility.
Our ‘Open Loop’ patent petitioned designs provide for an absolute ambidextrous right or
left hand engaging and disengaging function that is undetectable to a surgeon. Simply
put, a surgeon given our instrument designs, being behind a poster board obstructing his
or her view, would engage and disengage the locking mechanism with the exact same
maneuvers of the right or left hand and sense absolutely no difference from that in current
use.
This breakthrough solution that Vertu Medical Technologies now provides will serve to
prevent the unintentional harm to delicate structures due to unorthodox opening and
closing current available surgical instruments, being right hand biased, with the left hand.
Additionally, surgical residents will soon be able to use our technology to train
ambidextrously during medical school and residency training and carry the dexterity into
private practice. Most importantly, the reduction in harm to delicate structures logically
will result in future medical liability from using outdated standard conventional
instrument designs. It is our intention to dominate the twenty-billion-dollar yearly
surgical instrument market with licensing and or manufacturing applications.
During the interval past three years our petitioned “Open Loop Technology”
reconfiguration has undergone the scrutiny of finite element analysis for material
stressors as well as continuous repetitive engagement and disengagement of our
revolutionary locking mechanism nonstop without a single failure.
Pag
e6
2. CRITICAL CARE OXYGEN SATURATION DETECTION
DEVICES
BRIEF ABSTRACT:
Benefits: Allows rapid oxygen saturation determinations in critical patient
presentations where conventional pulse oximetry fails. Precludes more invasive
tests from preventing critical care patients from receiving necessary interventions.
Significantly increases the time for determining crucial vital sign information in
hemodynamically compromised patients. Reduces healthcare cost in critical care
settings.
Technology: Proprietary, patent pending technology providing temporary
enhanced microcirculation in the hemodynamically compromised patient thus
permitting accurate oxygen saturation determinations.
Market Impact: Estimate $200 million per year
Pag
e7
Industry Insights: Global Pulse Oximeters Market is expected to reach $1.901
billion by 2022, supported by a CAGR of 6.3% during the forecast period 2016 -
2022. The demand for pulse oximeters is expected to increase in the near future,
owing to efficient diagnosis of critical health conditions and ability to track the
health status of patients in home settings.
The global pulse oximeters market is driven by factors such as rise in incidence of
chronic diseases and surge in geriatric population. Moreover, increase in healthcare
expenditure in the emerging economies and high demand for proactive monitoring
are expected to unleash new opportunities for market players.
Development Stage: Engineered, tested, ready for market
Time to Market: 12 - 18 months
EXPANDED ABSTRACT:
Oxygenation occurs when oxygen molecules (O2) enter the tissues of the body. For
example, blood is oxygenated in the lungs, where the oxygen molecules travel
from the air and then into the blood. In medical terminology, oxygenation is
commonly used to refer to oxygen saturation. Again, in medical common use
oxygen saturation (SO2) is commonly referred to as “sats”, which is the
measurement of the percentage of hemoglobin binding sites in the bloodstream
occupied by oxygen.
A Pulse Oximeter is a device that relies on the light absorption characteristics of
saturated hemoglobin to give an indication of oxygen saturation, calculates the
peripheral oxygen saturation of a person and indirectly monitors the oxygen
saturation of a person or patient’s blood without having to take a direct sample
from the blood. The oxygen saturation changes with blood volume in the skin and
the pulse oximeter device is often attached to medical monitors so staff personnel
can always see a patient’s oxygenation. The intermittent or continuous evaluation
of a patient’s oxygenation is a crucial asset in determining the patient’s need for
oxygen supplementation and whether a patient is improving or worsening during
their treatment regarding sufficiently oxygenating tissues. Portable pulse oximeters
are available for home monitoring of blood oxygen. Home pulse oximeters are
typically used to monitor the respiratory status of patients with advanced lung or
heart pathology or to detect sleep apnea in the infant, for example. The
documentation of a patient’s O2 saturation is now considered the fifth vital sign
added commonly in clinic and hospital settings to a patient’s blood pressure, pulse,
Pag
e8
temperature and respiratory rate. The pulse oximeter has had wide adoption in the
United States since the late 1980’s.
A pulse oximeter is useful in any setting where a patient’s oxygenation is unstable,
including intensive care, operating, recovery, emergency and hospital ward
settings, pilots in unpressurized aircraft, for assessment of any patient’s
oxygenation, and for determining the effectiveness of or need for supplemental
oxygen. Assessing a patient’s need for oxygen is the most essential element to life;
no human life thrives in the absence of oxygen and therefore we establish medical
algorithms for serious medical presentations, assessing the airway and breathing
before any other parameter is inspected.
Because of their simplicity and speed, pulse oximeters are of critical importance in
emergency medicine and are also very useful for patients with advanced cardiac or
respiratory disease, especially COPD or CHF, and as mentioned to facilitate
diagnosis of sleep apnea and hypoventilation during sleep.
Having briefly discussed the mechanism and manner of the common use of pulse
oximetry we must consider those medical situations whereby pulse oximetry
readings are jeopardized and negatively affected. In the hypothermic patient the
patient’s peripheral blood flow has been constricted to protect the vital structures
and organs through enhanced macrocirculation. The diversion of peripheral blood
flow, changes in local PH and temperature effects on the oxygenation dissociation
curve also negatively affect the ability of pulse oximetry to accurately measure
oxygen saturation. Another situation negatively affecting pulse oximetry readings
is any condition causing shock in a patient. In this situation, the blood flow volume
is reduced peripherally, and the resulting acidosis and temperature changes
negatively affect the accuracy of pulse oximetry readings. Yet another medical
presentation with adverse effects on pulse oximetry is a patient in respiratory
extremis with the inability to adequately oxygenate the blood from peripheral
circulatory collapse, direct hypoventilation restricting phenomenon, or cardiac
compromise as with acute myocardial infarction or cardiac decompensation from
congestive heart failure, all adversely affecting oximetry readings with common
device application.
Vertu Medical addressed these, and other clinical presentations where pulse
oximetry readings are compromised and solved the problem in each, and every
example stated here. Through our patent petitioned breakthrough technologies in
pulse oximetry detection and readings, significantly enhanced patient oxygen
saturation monitoring can be provided to the patient presentations where
conventional pulse oximeters fail to obtain valid results. Our technologies will save
lives in the acute setting as well as save considerable health care expenses by
avoiding the need for more invasive procedures providing the same results as non-
invasive pulse oximetry.
Pag
e9
3. AIRWAY MANAGEMENT TECHNOLOGIES
BRIEF ABSTRACT:
Benefits: Improves endotracheal tube inserting precision, tube stabilization and
airway management to reduce errors, obtains vital physiological data, improves
patient outcomes, and minimize damage from intubation.
Technology: Proprietary, patent pending technology and system that facilitates
correct endotracheal tube placement, provides rapid and secure tube stabilization,
provides circuitry and software to interpret critical physiological parameters that is
transmittable through a responsive networked support system.
Market Impact: Estimate $150 million per year
Industry Insights:
Pag
e10
The global airway management devices market size was valued at USD 1.1 billion
in 2016 and is expected to grow at a CAGR of 7.6% during the forecast period.
The increasing prevalence of respiratory diseases is predicted to be one of the high
impact rendering drivers of this market. According to the WHO estimates, 65
million people suffer from moderate-to-severe COPD. Moreover, COPD is
predicted to be the third leading cause of death worldwide.
This high prevalence coupled with increase in anesthesia usage, due to increase in
surgeries, is expected to propel the demand for advanced devices, thus, exerting a
positive impact on the overall market growth. The increasing need of emergency
treatment for prolonged illnesses as well as protracted treatments associated with
lung diseases in children and adults is expected to drive the market growth.
Development Stage: Concepted, designed, prototype stage, not tested
Time to Market: 36-60 months
EXPANDED ABSTRACT:
Methods and devices are provided for, but not limited to; perform airway
intubation of mammals. In practicing the subject methods, trained individuals are
provided significantly improved methods and devices to intubate the airway of a
mammal, secure the endotracheal tube components provided to a mammal’s
perioral region utilizing unique gripping components, verify correct anatomical
placement of endotracheal tube components, provide supplementary ventilation for
a mammal in a non-interfering manner, and gather and analyze pertinent
physiological data from the mammal. Additionally, methods and devices are
provided for trained personnel to investigate, intervene and alter specific
conditions identified through present invention’s integrated system and provide
continuous and or interrupted monitoring of specific mammal physiological
parameters in a multitude of settings. Provided elastomeric circuitry permits
software and hardware to acquire and analyze gathered physiological data from an
intubated mammal. Present invention will be shown to significantly remediate a
multitude of prior art’s inabilities and complications well known to the medical
industry and significantly expand the scope of endotracheal tubes.
Pag
e11
4. PREVENTION OF SUDDEN CARDIAC DEATH IN ATHLETES
BRIEF ABSTRACT:
Benefits: Allows for rapid static and real time evaluations of an athlete’s heart
electrical signals and physiological structure in the form similar to conventional
cardiogram, X Ray and Echocardiogram. A.I. determined thresholds determine if
the athlete is within the safe zone or potentially susceptible to an undesirable
cardiac event.
Technology: Proprietary, patent pending monitoring system, software, and
communication protocol.
Market Impact: Estimate $500 million per year
Industry Insights:
Pag
e12
The cardiology market consists of cardiac assist devices, cardiac prosthetic
devices, cardiac rhythm management (CRM), cardiovascular monitoring and
diagnostic devices, cardiovascular surgical devices, electrophysiology, and
interventional cardiology.
With its $54.2 billion market opportunity by 2020, cardiology presents an attractive
target for non-traditional MedTech players—if they can offer high-impact solutions
supported by credible evidence has the potential to disrupt traditional clinical
research models.
Development Stage: Conceptual
Time to Market: 36-48 months
EXPANDED ABSTRACT:
Methods and devices to facilitate identification of cardiac abnormalities are
provided for, but not limited to, individuals seeking medical clearance physical
examinations for athletic participation. In practicing the subject methods, any
individual desiring to participate in organized sports is provided the opportunity,
means and devices to provide expanded data for present invention’s capability to
detect cardiac abnormalities. Invention’s unique methods and devices provide a
‘cost permissible’ means to gather data from athletes and integrally communicate
the input and output with software and devices provided with the device and
system. A means is provided for said data to be gathered and analyzed, inclusive of
athlete’s acoustical heart sounds, electrocardiograph signals and or echocardiogram
information. Present invention provides the means to record and analyze output
and input data to detect cardiac abnormalities utilizing system’s comparison
libraries. Additionally, by methods unique to present invention, software and
hardware are provided to ‘further’ enhance detection of underlying cardiac
abnormalities in athletes by simultaneously comparing acoustical, cardiac electrical
signals and echocardiogram information relationships in spatial and chronological
parameters to present invention’s reference libraries provided here within. Another
means unique to present invention is a scoring criterion applied to gathered and
analyzed data permitting an objective means to establish a novel ‘determinant’ for
coordinated recommendations and guidelines for all providers granting medical
clearance examinations, as example. Present invention will be shown to be a
solution to the previously cost prohibitive comprehensive cardiac screening
necessary to adequately detect underlying cardiac disorders in individuals of all
ages.
Pag
e13
5. REVOLUTIONARY SUMMATION EKG TECHNOLOGIES
BRIEF ABSTRACT:
Benefits: Revolutionizes conventional electrocardiogram signal detection and
clinical interpretation, integrates A.I. analysis resulting in more accurate diagnosis
while providing a globally responsive networked support system to modernize
conventional diagnostic libraries.
Technology: Proprietary, patent pending electrocardiogram system, software, and
communication protocol.
Market Impact: Estimate $2-5 billion per year
Industry Insights:
Pag
e14
The cardiology market consists of cardiac assist devices, cardiac prosthetic
devices, cardiac rhythm management (CRM), cardiovascular monitoring and
diagnostic devices, cardiovascular surgical devices, electrophysiology, and
interventional cardiology.
With its $54.2 billion market opportunity by 2020, cardiology presents an
attractive target for non-traditional MedTech players—if they can offer high-
impact solutions supported by credible evidence has the potential to disrupt
traditional clinical research models.
Development Stage: Conceptual
Time to Market: 36-48 months
EXPANDED ABSTRACT:
The present invention provides for methods and devices for a trained individual to
detect gather and transmit for analysis; the physiological cardiac emissions of a
mammal. In practicing the subject method(s), trained individuals are provided a
novel apparatus that is temporarily introduced into the esophagus of a mammal
wherein inventor’s apparatus comprises a series of inflatable elastomeric sensors
and electrodes integrally configured onto the outer surface of a longitudinal tubular
component wherein a vertical axis electrode and sensor array is provided. With the
cooperation of related submissions of inventor(s), a horizontal sensor array
apparatus is situated tangentially across the chest wall of said mammal wherein the
plurality and integration of invention’s components; as a system, provide a multi-
planar temporal relationship of sensors and electrodes in the x, y, and z planes.
Software unique to present invention permits user(s) to detect electrical, acoustical
and ultrasound information from a mammal’s cardiac emissions in a multitude of
manners novel to the applied field(s) of medicine. Present invention’s unique
methods and devices provide significant advancements over conventional cardiac
diagnostic modalities in regard to sensitivity and specificity of cardiac disorders
and additionally, through present invention’s means for coordinating transmission
of data through networks provided herein, a global database can be created to
encourage continual improvements and system learning features significantly
advantageous to the healthcare industry. Such applications of petitioned invention
to be integrated with Artificial Intelligence interpretations.
Pag
e15
6. VARIABLE FREQUENCY UV LIGHT STERILIZATION
BRIEF ABSTRACT:
Benefits: Eliminates static and airborne pathogens using a non-toxic, non-
chemical, rapid, improved ultra-violet exposure system
Technology: Proprietary, patent pending technology utilizing variable cycle ultra-
violet light frequency modulation.
Market Impact: Estimate $400 million per year
Industry Insights:
Transparency Market Research states that the global UV disinfection equipment
market was valued at US$1.62 bn in 2016 and is expected to be worth US$6.73 bn
by the end of 2025. During the forecast years of 2017 and 2025, the global market
Pag
e16
for UV disinfection equipment market is expected to register a CAGR of 17.40%.
The significant rise will be attributable to the process of disinfection used by UV
disinfection technology that leaves behind no disinfection by-products.
Furthermore, the cost-effective nature of this technology to ensure end-to-end
cleaning is also winning the market for UV disinfection equipment tremendous
popularity.
Development Stage: Conceptual
Time to Market: 24-36 months
EXPANDED ABSTRACT:
Means, methodology and devices are provided for incapacitating airborne life
forms; with or without potential properties of pathogenicity, in specific designated
arenas by the use of either pre calculated fixed frequency, variable interval
frequency, and or predetermined oscillating varying frequency ranges of UV light
radiation. Methods and devices are provided to incapacitate, to a desired degree of
efficacy, the survivability and pathogenic potential of micro and macro airborne
life forms in specific locations wherein airborne contact with any portion of a
mammal with said potentially pathogenic organisms may cause disease to said
portion or entity of a mammal as a whole. In practicing the subject methods,
present invention devices utilizing ultraviolet light generators; specifically those
emitting ranges of UV-A, UV-B, and UV-C light radiation; such as permitted with
mercury bulb generator sources; for example, are incorporated and configured to
be temporarily or permanently housed in specific pertinent atmospheric arenas. An
example of such pertinent arena could be the atmospheric environment within
health care facilities.
The current invention is designed to emit varying ranges of UV light emissions in
fixed wavelengths, varying wavelengths, and or harmonically oscillating
ultraviolet radiation to a determined atmospheric volume. Present invention design
permits function in a single mode or any combination of said alternatives
designated by inventors as Harmonic and Non-Harmonic Phases.
Alternative embodiments of the present invention are provided using adjunctive
cooperation with sound wave frequencies and directional ultrasonic coupling of
said sound wave frequencies to prevent damage to sensitive equipment and
encourage continual improvements and artificial intelligence system learning
features significantly advantageous to the healthcare industry.
Pag
e17
7. SUMMATION TECHNOLOGIES APPLIED TO
PHYSIOLOGIC DATA DETECTION
BRIEF ABSTRACT:
Benefits: Allows for rapid and accurate health assessments with complete
physiological data presented with A.I. assessment for precise diagnosis.
Technology: Proprietary, patent pending monitoring system, software, and
communication protocol.
Market Impact: Estimate $2 billion per year
Industry Insights:
The global clinical laboratory tests market size was valued at USD 165.48 billion
in 2018. It is expected to expand at a CAGR of 7.1% during the forecast period.
Rise in prevalence of chronic disorders along with heightened awareness among
health-conscious people has encouraged the growth of the market.
Development Stage: Conceptual
Pag
e18
Time to Market: 48-60 months
EXPANDED ABSTRACT:
An Intercalated System of integrated and cooperative Methods, Devices and
Software is provided to identify, interpret, analyze, store and remotely transfer
physiologic data from a mammal. Input and output data may be individually and or
simultaneously and cooperatively integrated and compared in invention’s novel
summation format and software permitting a significantly enhanced sensitivity and
specificity in identification of specific abnormalities and disorders of a mammal.
Such integrated and simultaneous comparison of certain physiologic parameters
will significantly advance Health Care Specialists’ ability to detect underlying
cardiac abnormalities. For example, detect symptoms that were undetectable with
prior art and science, and give new understanding as to which identified
abnormalities are clinically significant. Invention provides a means to develop and
create new diagnostic scoring criterion to be utilized and expanded on in the fields
of Cardiology, Critical Care and Emergency Medicine; to name a few, both in the
acute and critical phase as well as with routine testing. Extrapolated data provided
by methods and software here within will be utilized to create novel databases and
libraries of clinical determinations of normal, normal variance and or significant
abnormalities which will greatly assist health care providers’ diagnostic abilities
and acuity.
Pag
e19
8. FEMININE HYGIENE TECHNOLOGIES
BRIEF ABSTRACT:
Benefits: Provides novel means for feminine hygiene, reduces potential infections
and eliminates the environmental risks attached with the disposal of conventional
feminine hygiene products.
Technology: Proprietary, patent pending, chemical free system designs
Market Impact: Estimate $350 million per year
Industry Insights:
Global Feminine Hygiene Market was valued approximately USD 21.8 billion in
2016 is anticipated to grow with a healthy growth rate of more than 3.47% over the
forecast period 2017-2025. Global Feminine Hygiene Market is expected to reach
USD 44.3 billion by 2025. Growth in the organized retail market and rapid
urbanization are a reason for the rising demand for organic products These are
some of the factors that are driving the global feminine hygiene products market.
Despite these factors, the market is restrained by the environmental risks attached
with the disposal of most feminine hygiene products like sanitary pads and
tampons.
Development Stage: Prototype, engineered, tested.
Time to Market: 12-24 months
EXPANDED ABSTRACT:
The petitioned inventions provide for methods and devices for an individual to
cleanse the internal intraluminal mucosal cavities and or external genitalia. The
novel devices are provided for an individual to discreetly and rapidly perform
personal hygiene cleansing of their genitalia and or the genitalia of other
individual(s) including; but not limited to, the vaginal vault and vulva, perineum
and perianal area, anus and rectal chamber, pubic mons and groin region, and or
any portion of an individual’s penis and scrotum. The present invention may also
provide a means of introducing internally and or externally, a variety of solutions
with varying properties to be utilized for purposes such as; but not limited to:
spermicidal agents, water, soaps, glycerin, mineral oil, antimicrobials, antifungal
agents, antiviral agents, hormones, medicines, PH buffering agents, deodorant
agents, other lubricating agents, aroma agents and or any combination of said
agents. Present inventions provide said functions by means of a novel hygienic
device with a plurality of components. Present invention is additionally
inexpensive, dispensable, and biodegradable and intended for a one-time use.
Pag
e20
9. BIOPHASIC SENSORY STIMULATION TECHNOLOGIES
BRIEF ABSTRACT:
Benefits: Devices and technologies providing novel treatment modalities in a
variety of medical fields such as pain management, collagen stimulation, wound
and bone healing, edema, migraines, seizures, concentration as well as natural
athletic performance enhancement and addiction management, for example.
Technology: Proprietary, patent pending system, software, and protocol.
Market Impact: Estimate $3-5 billion per year
Development Stage: Prototype, engineered, tested
Time to Market: 24-36 months
EXPANDED ABSTRACT:
The petitioned technologies provide a revolutionary biophasic sensory stimulation
modality wherein various systems of a mammal react in such a manner previously
unutilized in modern medicine. Such breakthrough technology provides a
disruptive novel means and methodology for applied medicine to integrate the
Pag
e21
petitioned stimulatory devices in virtually every field of science and medicine. Our
proprietary technology will potentially provide a paradigm shift in treatment
applications and adjuncts such as acute and chronic pain management, wound and
bone healing, collagen formation, edema treatment, vascular insufficiency,
migraine headache control, seizure prevention and abatement, natural athletic
performance enhancement and recovery, concentration and recall, biofeedback and
relaxation and addiction management, for example.
10. INFANT ENVIRONMENT TECHNOLOGIES
BRIEF ABSTRACT:
Benefit: Prevention of infant deaths from preventable causes while in a crib, while
providing a controlled stimulus environment that enhances both the psychological
and physical health of infants. Technology: Dynamic controlled atmosphere,
sensory mattresses and linens, A.I. guided software, and advanced monitoring
systems ties to a responsive networked support system.
Market Impact: $200 million per year
Pag
e22
Industry Insights:
The global baby product market size was valued at USD 10.91 billion in 2017 and
is expected to register a CAGR of 5.5% over the forecast period on account of
rising spending capability and changing lifestyles. Rapid urbanization and growing
middle-class population across several developing regions are driving the market
further. Changing lifestyle, particularly in developing countries, has encouraged
the adoption of convenience-oriented routine, making these items desirable, which
will fuel the industry growth over the forecast period.
Development Stage: Conceptual
Time to Market: 3 - 5 years
EXPANDED ABSTRACT:
Vertu Medical provides comprehensive and patent petitioned proprietary means
and methods for the prevention of adverse outcomes in the infant and early
childhood years. Through years of dedicated research and investigations our
proprietary innovations and technologies will soon serve to reduce, if not
eliminate, preventable causes of sudden infant death syndrome and other well
documented adverse outcomes encountered with neonates. Our vast network of
providers, with decades of experience in the related fields, have come together to
compile a comprehensive portfolio of solutions and technologies addressing every
known potential adverse outcome for babies in the crib stage of life.